Just Answers - Computers and Technology

Advances in nanotechnology have proven that incredible progress is not only possible today and in the future, it is pretty well inevitable. Fantastic advances in

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

nanotechnologic medical research have resulted in life saving techniques that were unheard of even a decade ago.

Genetic engineering research and development p

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ovides a means of revolutionizing agricultural output by enhancing crop yields while encouraging a decrease in the necessity for pesticides. It also holds out a

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

promise of attaining newer, improved species of plants and animals, the ability to someday replace or supplement reproduction with cloning and the hope that cure

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

will be developed for many fatal and debilitating diseases, which can only result in increased life spans and improved quality of life.

Robotic engineers firml

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

believe that development of a truly intelligent machine that is capable of performing most tasks better than humans will be perfected within our lifetime. They

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

envision a time when a highly organized system of machines will perform all tasks with little or no human input.

It is not hard to imagine the revolutionary ad

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ancements that are possible if nanotechnology, genetic engineering and robotics combine their expertise in future technological advancements. Either the result w

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ll be a utopian world free of disease or pestilence or a jumbled chaos of grey goo and confusion.

Regardless of the outcome, it is inevitable that the future ho

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ds profound changes because of nanotechnology, genetic engineering and robotics, whether the accomplishments are made on their own or as a result of a coordinate

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

effort. Along with the imminent progression, however, we must also be aware of the philosophical, moral and ethical issues that will come about as a result of

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

biological change.

In addition to the potential threat from the unleashed power of nanotechnology based scientific advancements, there is also the promise of an

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

improved future for mankind and the world in which he dwells. The line of demarcation is thin and easily crossed and therefore great care and planning must go h

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

nd in hand with technological advances.

Naysayers are quick to point out the many pitfalls of unbridled nanotechnology, genetic engineering and robotics researc

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

and implementation; however, to the chagrin of futurists, these non-progressive individuals fail to fully conceive of the many benefits these scientific advance

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ents can and will provide. Progressive thinkers are quick to embrace the very real possibility of incredibly low-cost solar power, cures for debilitating diseas

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

e via intensification of the human immune system, the ability to clean up our environment and the overall improvement of human existence that is not only possibl

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

but entirely plausible in the very near future because of nanotechnology, genetic engineering and robotics.

So, are nanotechnology, genetic engineering and rob

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tics to be feared as an impending doomsday event or should they be embraced as miracles of the future? Only by carefully reviewing the past while embracing the

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

uture will we be able to tell. After all, if we are willing to build an artificial brain, we must be willing to construct one that is able to see what we cannot

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justanswers.org.ua/article/168807/justanswers-Nanotechnology-Genetic-Engineering--Robotics--Doomsday-or-Miracle.html">Nanotechnology, Genetic Engineering & Robotics - Doomsday or Miracle?</a>

BB link (for phorums):
[url=http://www.justanswers.org.ua/article/168807/justanswers-Nanotechnology-Genetic-Engineering--Robotics--Doomsday-or-Miracle.html]Nanotechnology, Genetic Engineering & Robotics - Doomsday or Miracle?[/url]

When it comes to writing your own ebook, there is nothing more satisfying than seeing your work sell. Unless you are creating products to give away, the main point of creating your own ebook is to sell for profit or get back end sales.

Lynn VanDyke delivers part 3 of 4 in this article series devoted to those looking to beef up their online business success.

The stock market setback has awakened the fear for many people that they might, in fact, outlive their money. For many of these folks, the only asset they own that has truly appreciated is their home. Suddenly they are looking at their home as a source of wealth to be tapped for retirement income.

Tags

Links

Just Answers - Nanotechnology, Genetic Engineering & Robotics - Doomsday or Miracle?

Related Articles: